CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
57 hedge funds and large institutions have $26.6M invested in CureVac in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 26 reducing their positions, and 49 closing their positions.
68% more call options, than puts
Call options by funds: $249K | Put options by funds: $148K
6.15% less ownership
Funds ownership: 8.79% → 2.64% (-6.2%)
39% less funds holding
Funds holding: 94 → 57 (-37)
58% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 26
75% less capital invested
Capital invested by funds: $105M → $26.6M (-$78.9M)
76% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 49
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.81M |
| 2 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
+$3.33M |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$1.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$738K |
| 5 |
Jane Street
New York
|
+$664K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$24.5M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$12.4M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$9.23M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$5.35M |
| 5 |
WIC
Water Island Capital
New York
|
-$4.11M |
CVAC Hedge Fund Activity: Q4 2025 in Review
57 institutional investors reported a position in CureVac (CVAC) for Q4 2025, worth a combined $26.6M — down 75% from $105M a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of CVAC and 12 opened new positions — a net loss of 37 holders — while 26 trimmed existing stakes and 11 added.
The largest buyer was BlackRock, adding an estimated $4.81M. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $24.5M sold.
- 57 institutional investors held CureVac (CVAC) as of Q4 2025, down from 94 in Q3 2025.
- Funds reported $26.6M of CureVac stock for Q4 2025, down 75% quarter-over-quarter.
- 12 funds opened new CureVac positions in Q4 2025 and 49 closed out, a net change of -37 holders.
- The largest CureVac buyer in Q4 2025 was BlackRock, an estimated $4.81M added.
- The largest CureVac seller in Q4 2025 was Glazer Capital LLC, an estimated $24.5M sold.
Based on aggregated 13F filings for Q4 2025.